Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
| ID | DOID:0070784 |
| Name | hormone receptor-positive breast cancer |
| Definition | A breast cancer characterized by the presence of at least one of the estrogen or progesterone receptors. |
| Source | DiseaseOntology.org |
| Alt Ids | |
| Xrefs |
|
| Path | disease disease of cellular proliferation cancer organ system cancer breast cancer hormone receptor-positive breast cancer |
| Molecular Profile | Therapy | Indication/Tumor Type | Response Type | Profile Response Detail |
|---|
| Clinical Trial | Phase | Therapies | Title | Recruitment Status | Covered Countries | Other Countries |
|---|---|---|---|---|---|---|
| NCT07701941 | Phase Ib/II | Trastuzumab deruxtecan Patritumab deruxtecan + Trastuzumab deruxtecan | A Study of Patritumab Deruxtecan (HER3-DXd) in Combination With Trastuzumab Deruxtecan (T-DXd) in Participants With HR-Positive, HER2-Low or HER2-Ultralow Unresectable or Metastatic Breast Cancer | Recruiting | USA | ITA | FRA | ESP | BEL | 3 |
| NCT07807345 | Phase I | Pembrolizumab + STRO-006 STRO-006 | Phase 1 Study of STRO-006 in Adults With Refractory Solid Tumors That Are Recurrent or Metastatic | Recruiting | USA | 0 |